Literature DB >> 18494047

Mechanisms of biliary carcinogenesis and growth.

Candace Wise1, Metaneeya Pilanthananond, Benjamin-F Perry, Gianfranco Alpini, Michael McNeal, Shannon-S Glaser.   

Abstract

Cholangiocarcinoma is a rare cancer originating from the neoplastic transformation of the epithelial cells (i.e. cholangiocytes) that line the biliary tract. The prognosis for patients with cholangiocarcinoma is grim due to lack of viable treatment options. The increase in world-wide incidence and mortality from cholangiocarcinoma highlights the importance of understanding the intracellular mechanisms that trigger the neoplastic transformation of cholangiocytes and the growth of biliary cancers. The purpose of the following review is to address what has been learned over the past decade concerning the molecular basis of cholangiocarcinogenesis. The material presented is divided into two sections: (1) mechanisms regulating neoplastic transformation of cholangiocytes; and (2) factors regulating cholangiocarcinoma growth. An understanding of the growth regulatory mechanisms of cholangiocarcinoma will lead to the identification of therapeutic targets for this devastating cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18494047      PMCID: PMC2712163          DOI: 10.3748/wjg.14.2986

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  Cholangiocarcinoma.

Authors:  Tushar Patel
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-01

Review 2.  Cholangiocarcinoma.

Authors:  Konstantinos N Lazaridis; Gregory J Gores
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

3.  Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.

Authors:  Domenico Alvaro; Barbara Barbaro; Antonio Franchitto; Paolo Onori; Shannon S Glaser; Gianfranco Alpini; Heather Francis; Luca Marucci; Paola Sterpetti; Stefano Ginanni-Corradini; Andrea Onetti Muda; David E Dostal; Adriano De Santis; Adolfo F Attili; Antonio Benedetti; Eugenio Gaudio
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 4.  Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis.

Authors:  Marco Marzioni; Giammarco Fava; Antonio Benedetti
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 5.  Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver.

Authors:  Domenico Alvaro; Maria Grazia Mancino; Shannon Glaser; Eugenio Gaudio; Marco Marzioni; Heather Francis; Gianfranco Alpini
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

6.  mir-29 regulates Mcl-1 protein expression and apoptosis.

Authors:  J L Mott; S Kobayashi; S F Bronk; G J Gores
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

Review 7.  Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  J Hepatol       Date:  2006-09-25       Impact factor: 25.083

8.  gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway.

Authors:  Giammarco Fava; Luca Marucci; Shannon Glaser; Heather Francis; Sharon De Morrow; Antonio Benedetti; Domenico Alvaro; Julie Venter; Cynthia Meininger; Tushar Patel; Silvia Taffetani; Marco Marzioni; Ryun Summers; Ramona Reichenbach; Gianfranco Alpini
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

9.  Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.

Authors:  Sharon DeMorrow; Shannon Glaser; Heather Francis; Julie Venter; Bradley Vaculin; Shelley Vaculin; Gianfranco Alpini
Journal:  J Biol Chem       Date:  2007-02-28       Impact factor: 5.157

10.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

View more
  14 in total

Review 1.  [Pathological anatomical characteristics of Klatskin tumors. Classification, current molecular biological aspects, prognosis factors].

Authors:  J Munding; A Tannapfel
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

2.  A new variant of bile duct duplication with coexistence of distal cholangiocarcinoma.

Authors:  Ilkay Kosar; Hilmi Ataseven; Ozlem Yönem; Erol Cakmak; Ozdemir Ozer; Hatice Ozer; Omer Topçu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

Review 3.  Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.

Authors:  Gábor Lendvai; Tímea Szekerczés; Idikó Illyés; Réka Dóra; Endre Kontsek; Alíz Gógl; András Kiss; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; Katalin Borka
Journal:  Pathol Oncol Res       Date:  2018-11-17       Impact factor: 3.201

4.  Cholangiocarcinoma following external beam radiotherapy: A report of two cases.

Authors:  Anisha Kulkarni; Justin S Gundara; Anthony J Gill; Thomas J Hugh; Jaswinder S Samra
Journal:  Oncol Lett       Date:  2017-05-03       Impact factor: 2.967

5.  New insights on cholangiocarcinoma.

Authors:  Manuela Gatto; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

Review 6.  Hilar cholangiocarcinoma: pathology and tumor biology.

Authors:  Dong Kuang; Guo-Ping Wang
Journal:  Front Med China       Date:  2010-11-25

7.  Gallbladder carcinoma in a pregnant patient with Crohn's disease complicated with gallbladder involvement.

Authors:  Shada Attraplsi; Rima M Shobar; Ihab Lamzabi; Rana Abraham
Journal:  World J Gastrointest Oncol       Date:  2013-02-15

8.  Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation.

Authors:  S DeMorrow
Journal:  Dig Liver Dis       Date:  2008-12-27       Impact factor: 4.088

9.  Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro.

Authors:  Thorsten Lieke; Wolf Ramackers; Sabine Bergmann; Jürgen Klempnauer; Michael Winkler; Johannes Klose
Journal:  BMC Cancer       Date:  2012-10-11       Impact factor: 4.430

10.  Vitamin D3 regulates cell viability in gastric cancer and cholangiocarcinoma.

Authors:  Sungmin Baek; Young-Suk Lee; Hye-Eun Shim; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Sae-Ock Oh
Journal:  Anat Cell Biol       Date:  2011-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.